Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19
Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …
[HTML][HTML] Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
A Wagner, A Guzek, J Ruff, J Jasinska… - Communications …, 2021 - nature.com
Background In spring 2020, at the beginning of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pandemic in Europe, we set up an assay system for large …
coronavirus 2 (SARS-CoV-2) pandemic in Europe, we set up an assay system for large …
Natural language processing enabling COVID-19 predictive analytics to support data-driven patient advising and pooled testing
Objective The COVID-19 (coronavirus disease 2019) pandemic response at the Medical
University of South Carolina included virtual care visits for patients with suspected severe …
University of South Carolina included virtual care visits for patients with suspected severe …
COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness
MW Reynolds, Y Xie, KB Knuth, CD Mack… - Infection and Drug …, 2022 - Taylor & Francis
Purpose Coronavirus disease 2019 (COVID-19) has highlighted the need for new methods
of pharmacovigilance. Here, we use adult community volunteers to obtain systematic …
of pharmacovigilance. Here, we use adult community volunteers to obtain systematic …
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) instrument in patients with coronavirus disease 2019
SA Richard, NJ Epsi, S Pollett… - Open Forum …, 2021 - academic.oup.com
Abstract Background The inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) is a
patient-reported outcome data collection instrument assessing symptoms of viral respiratory …
patient-reported outcome data collection instrument assessing symptoms of viral respiratory …
Identification of a vulnerable group for post-acute sequelae of SARS-CoV-2 (PASC): people with autoimmune diseases recover more slowly from COVID-19
N Dreyer, N Petruski-Ivleva, L Albert… - … journal of general …, 2021 - Taylor & Francis
Purpose Evidence is emerging that a significant percentage of COVID-19 cases experience
symptom persistence beyond 30 days and go on to develop post-acute sequelae. Our …
symptom persistence beyond 30 days and go on to develop post-acute sequelae. Our …
[HTML][HTML] Chest CT-derived muscle analysis in COVID-19 patients
M Antonarelli, M Fogante - Tomography, 2022 - mdpi.com
Background: sarcopenia is a predictor of unfavorable outcomes, but its prognostic impact on
patients with COVID-19 is not well known. To evaluate the association between the chest …
patients with COVID-19 is not well known. To evaluate the association between the chest …
[HTML][HTML] How frequent are acute reactions to COVID-19 vaccination and who is at risk?
N Dreyer, MW Reynolds, L Albert, E Brinkley, T Kwon… - Vaccine, 2022 - Elsevier
Introduction Our objective was to describe and compare self-reported side effects of COVID-
19 vaccines in the USA. Methods A web-based registry enrolled volunteers who received a …
19 vaccines in the USA. Methods A web-based registry enrolled volunteers who received a …
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design
MW Reynolds, A Secora, A Joules… - Journal of …, 2022 - becarispublishing.com
Aim: It is important to assess if clinical trial efficacy translates into real-world effectiveness for
COVID-19 vaccines. Materials & methods: We conducted a modified test-negative design …
COVID-19 vaccines. Materials & methods: We conducted a modified test-negative design …
Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry
J Largent, Y Xie, KB Knuth, S Toovey, MW Reynolds… - BMJ open, 2023 - bmjopen.bmj.com
Objective To describe cognitive symptoms in people not hospitalised at study enrolment for
SARS-CoV-2 infection and associated demographics, medical history, other …
SARS-CoV-2 infection and associated demographics, medical history, other …